St. Elizabeth Healthcare is one of 30 organizations across the nation that has been invited by the White House to participate in President Barack Obama’s Precision Medicine Initiative Summit today.
This event brings together 150 leaders from the Federal government, private sector, academia, research organizations, and patient advocacy groups to highlight precision medicine efforts, share best practices, and identify opportunities for further collaboration.
President Obama will attend the Summit to hear individual views from attendees and foster collaboration around this important initiative. The Summit will take place from 10 a.m. to Noon and is available via live stream here .
Sarah Giolando, Chief Strategy Officer of St. Elizabeth Healthcare has been invited to attend the Summit to discuss its initiative to use precision medicine to identify the appropriate medication to treat depression and other behavioral health disorders, based on a patient’s genetic profile. This initiative is often referred to as pharmacogenomics.
Studies (Hall-Flavin 2012, Winner 2013) have demonstrated that when physicians used the results of pharmacogenomics tests to inform medication selection, patients achieved better efficacy, with less side effects, in less time, at a lower costs.
“Pharmacogenomics provides physicians better insight as to which medications will work best for a patient,” Giolando said. “It truly takes the “guesswork” out of medicine and results in the patient getting the right medication and the right dose, the first time. St. Elizabeth is always looking for ways to leverage innovative approaches that improve patient experience, patient care and reduce costs for patients – effectively achieving the ‘triple aim’ of health.”
The White House is convening this summit just more than a year after President Obama announced his Precision Medicine Initiative.
The President allocated $215 million in the 2016 budget to the initiative, providing funding to the National Institute of Health (NIH), the National Cancer Institute (NCI), the Food and Drug Administration (FDA) and the Office of the National Coordinator for Health Information Technology (ONC).
Precision Medicine tailors treatment and prevention strategies to people’s unique characteristics, including their genome sequence, microbiome composition, health history, lifestyle, and diet.
“The impact of getting the medication wrong for a behavioral health diagnosis can be frustrating, or in some cases even tragic when a patient does not respond to a medication treatment,” says Dr. Anthony Alvarez, St. Elizabeth Behavioral Health Medical Director. “We need to use all of the tools available to us to get it right the first time.”
Sunnie Southern, CEO of Viable Synergy, is also attending the Summit. St. Elizabeth is collaborating with Viable Synergy to provide a Digital Resource Center called the Precision Medicine Innovation Station.
Patients and families will be able to access educational resources, identify clinicians who offer Precision Medicine testing, sign-up for supporting services such as genetic counselors and medication financial assistance programs, and join peer support communities.
More information on the President’s Precision Medicine Initiative and St. Elizabeth’s commitment can be found here.
St. Elizabeth Healthcare operates six major facilities throughout Northern Kentucky and more than 115 primary care and specialty office locations in Kentucky, Indiana and Ohio.
St. Elizabeth Healthcare